文献速递系统性红斑狼疮

在兩個獨立隊列中驗證的新型IgG和IgA自身抗體與系統性紅斑狼瘡疾病活動度相關並決定器官表現:抗LIN28A、抗HMGN5、抗IRF5和抗TGIF1的意義

Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1.
PubMed 文献 · Ann Rheum Dis · 2025-05-09

本研究利用蛋白微陣列在發現隊列(SLE 196例 vs 健康對照110例)和獨立驗證隊列(SLE 30例 vs 健康對照83例)中篩選並驗證了89種IgG和66種IgA差異豐度自身抗體。IgG抗LIN28A、IgG抗HMGN5以及抗IRF5和抗TGIF1的雙同型抗體與SLEDAI-2K≥10相關,且與狼瘡低疾病活動狀態負相關。IgG抗LIN28A在中樞神經系統受累患者中陽性率達53%,高於抗雙鏈DNA的20%。

要点

  • 驗證了89種IgG和66種IgA差異豐度自身抗體與SLE疾病活動度相關。
  • IgG抗LIN28A、IgG抗HMGN5及抗IRF5、抗TGIF1雙同型抗體與SLEDAI-2K≥10相關。
  • IgG抗LIN28A在中樞神經系統受累患者中陽性率為53%,高於抗雙鏈DNA的20%。

核心结论

  • 新型IgG和IgA自身抗體包括IgG抗LIN28A、IgG抗HMGN5、IgG和IgA抗IRF5及IgG和IgA抗TGIF1與SLE疾病活動度相關,並在多種器官表現中高度豐富。

研究设计与样本

  • 研究從歐洲PRECISESADS項目中納入發現隊列(SLE 196例 vs 健康對照110例;NTC02890121)和獨立驗證隊列(SLE 30例 vs 健康對照83例;NCT02890134),使用i-Ome Discovery微陣列篩選血漿中針對1609種蛋白自身抗原的IgG和IgA血清反應性。

主要发现

  • 驗證了89種IgG和66種IgA差異豐度自身抗體。
  • IgG抗LIN28A、IgG抗HMGN5以及抗IRF5和抗TGIF1的雙同型抗體與SLEDAI-2K評分≥10相關,與狼瘡低疾病活動狀態負相關,並在跨器官表現的活動性疾病亞組中高度流行。
  • IgG抗LIN28A水平超過陽性臨界值的患者在中樞神經系統受累中佔53%,該患病率高於抗雙鏈DNA的20%;在腎臟活動患者中佔47%。
  • 針對RNA結合蛋白(包括抗LIN28A)的IgG和IgA差異豐度自身抗體簇與中樞神經系統受累相關。
  • IgA抗FOSL2僅在肌肉骨骼活動患者中升高;涉及DNA結合和修復的富集通路在各種表現之間顯示相當大的重疊。

关键数值与推荐

  • IgG抗LIN28A水平超過陽性臨界值在中樞神經系統受累患者中為53%,在腎臟活動患者中為47%,抗雙鏈DNA在中樞神經系統受累患者中為20%。

局限性

  • 原文未報告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to identify and validate novel autoantibodies that reflect global and organ-specific disease activity in systemic lupus erythematosus (SLE). METHODS: Plasma samples were screened for IgG and IgA seroreactivity against 1609 protein autoantigens using a microarray (i-Ome Discovery; Sengenics). We determined differentially abundant autoantibodies (daAAbs) in patients with SLE vs healthy controls within a discovery (n = 196 vs n = 110; NTC02890121) and an independent validation cohort (n = 30 vs n = 83; NCT02890134) from the European PRECISESADS project. Validated daAAbs were analysed in relation to global and organ-specific disease activity using linear and logistic regression, along with daAAb target pathway enrichment analysis. RESULTS: We validated 89 IgG and 66 IgA daAAbs. IgG anti-LIN28A, IgG anti-HMGN5, and both isotypes for anti-IRF5 and anti-TGIF1 were associated with a SLE disease activity index 2000 score of ≥10, negatively associated with lupus low disease activity state, and highly prevalent in subgroups with active disease across organ manifestations. IgG anti-LIN28A levels exceeded the cutoff for positivity in 53% of patients with central nervous system (CNS) involvement, a prevalence higher than that observed for anti-double-stranded DNA (20%) and 47% of patients with renal activity. A cluster of IgG and IgA daAAbs against RNA-binding proteins, including anti-LIN28A, was linked to CNS involvement. IgA anti-FOSL2 was elevated uniquely in patients with musculoskeletal activity. Enriched pathways involving DNA binding and repair showed considerable overlap across manifestations. CONCLUSIONS: Novel IgG and IgA autoantibodies, including IgG anti-LIN28A, IgG anti-HMGN5, IgG and IgA anti-IRF5, and IgG and IgA anti-TGIF1 were associated with SLE disease activity and highly abundant across organ manifestations.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Lindblom J, Lagutkin D, Sherina N, et al. Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1. Ann Rheum Dis. 2025. PMID: 40348637. doi:10.1016/j.ard.2025.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。